MRP4 is responsible for the efflux transport of mycophenolic acid β-d glucuronide (MPAG) from hepatocytes to blood

References

• Berendsen HJC, Postma JPM, van Gunsteren WF, et al. (1984). Molecular dynamics with coupling to an external bath. J Chem Phys 81: 3684–90.
   Web of Science ®Google Scholar
• Berthier J, Arnion H, Saint-Marcoux F, Picard N. (2019). Multidrug resistance-associated protein 4 in pharmacology: overview of its contribution to pharmacokinetics, pharmacodynamics and pharmacogenetics. Life Sci 231:116540.
   PubMed Web of Science ®Google Scholar
• Bullingham RE, Nicholls AJ, Kamm BR. (1998). Clinical pharmacokinetics of mycophenolate mofetil. Clin Pharmacokinet 34:429–55.
   PubMed Web of Science ®Google Scholar
• Case DA, Ben-Shalom IY, Brozell SR, et al. (2018), AMBER 2018, University of California, San Francisco.
   Google Scholar
• Chandra S, Fukuda T, Mizuno K, et al. (2018). Micafungin antifungal prophylaxis in children undergoing HSCT: can we give higher doses, less frequently? A pharmacokinetic study. J Antimicrob Chemother 73:1651–8.
   PubMed Web of Science ®Google Scholar
• Chantemargue B, Di Meo F, Berka K, et al. (2018). Structural patterns of the human ABCC4/MRP4 exporter in lipid bilayers rationalize clinically observed polymorphisms. Pharmacol Res 133:318–27.
   PubMed Web of Science ®Google Scholar
• Ci L, Kusuhara H, Adachi M, et al. (2007). Involvement of MRP4 (ABCC4) in the luminal efflux of ceftizoxime and cefazolin in the kidney. Mol Pharmacol 71:1591–7.
   PubMed Web of Science ®Google Scholar
• Colom H, Lloberas N, Andreu F, et al. (2014). Pharmacokinetic modeling of enterohepatic circulation of mycophenolic acid in renal transplant recipients. Kidney Int 85:1434–43.
   PubMed Web of Science ®Google Scholar
• Cornell WD, Cieplak P, Bayly CI, Kollman PA. (1993). Application of RESP charges to calculate conformational energies, hydrogen bond energies, and free energies of solvation. J Am Chem Soc 115:9620–31.
   Web of Science ®Google Scholar
• Darden T, York D, Pedersen L. (1993). Particle mesh Ewald: an N⋅log (N) method for Ewald sums in large systems. J Chem Phys 98:10089–92.
   Web of Science ®Google Scholar
• Davies NM, Anderson KE. (1997). Clinical pharmacokinetics of diclofenac. Therapeutic insights and pitfalls. Clin Pharmacokinet33:184–213.
   PubMed Web of Science ®Google Scholar
• Davies NM. (1998). Clinical pharmacokinetics of ibuprofen. The first 30 years. Clin Pharmacokinet 34:101–54.
   PubMed Web of Science ®Google Scholar
• Deeley RG, Westlake C, Cole SPC. (2006). Transmembrane transport of endo- and xenobiotics by mammalian ATP-binding cassette multidrug resistance proteins. Physiol Rev 86:849–99.
   PubMed Web of Science ®Google Scholar
• Elbarbry FA, Shoker AS. (2007). Therapeutic drug measurement of mycophenolic acid derivatives in transplant patients. Clin Biochem 40:752–64.
   PubMed Web of Science ®Google Scholar
• El-Sheikh AAK, Koenderink JB, Wouterse AC, et al. (2014). Renal glucuronidation and multidrug resistance protein 2-/multidrug resistance protein 4-mediated efflux of mycophenolic acid: interaction with cyclosporine and tacrolimus. Transl Res 164:46–56.
   PubMed Web of Science ®Google Scholar
• El-Sheikh AAK, van den Heuvel JJMW, Koenderink JB, Russel FGM. (2007). Interaction of nonsteroidal anti-inflammatory drugs with multidrug resistance protein (MRP) 2/ABCC2- and MRP4/ABCC4-mediated methotrexate transport. J Pharmacol Exp Ther 320:229–35.
   PubMed Web of Science ®Google Scholar
• El-Sheikh AAK, van den Heuvel JJMW, Krieger E, et al. (2008). Functional role of arginine 375 in transmembrane helix 6 of multidrug resistance protein 4 (MRP4/ABCC4). Mol Pharmacol 74:964–71.
   PubMed Web of Science ®Google Scholar
• Fahr A. (1993). Cyclosporin clinical pharmacokinetics. Clin Pharmacokinet 24:472–95.
   PubMed Web of Science ®Google Scholar
• Franklin TJ, Cook JM. (1969). The inhibition of nucleic acid synthesis by mycophenolic acid. Biochem J 113:515–24.
   PubMed Web of Science ®Google Scholar
• Gould IR, Skjevik AA, Dickson CJ, et al. (2018). Lipid17: a comprehensive AMBER force field for the simulation of zwitterionic and anionic lipids.
   Google Scholar
• Hanwell MD, Curtis DE, Lonie DC, et al. (2012). Avogadro: an advanced semantic chemical editor, visualization, and analysis platform. J Cheminformatics 4:17.
   PubMed Web of Science ®Google Scholar
• Harding SM, Monro AJ, Thornton JE, et al. (1981). The comparative pharmacokinetics of ceftazidime and cefotaxime in healthy volunteers. J Antimicrob Chemother 8 Suppl B:263–72.
   PubMed Web of Science ®Google Scholar
• Järvinen E, Troberg J, Kidron H, Finel M. (2017). Selectivity in the efflux of glucuronides by human transporters: MRP4 is highly active toward 4-methylumbelliferone and 1-naphthol glucuronides, while MRP3 exhibits stereoselective propranolol glucuronide transport. Mol. Pharm 14:3299–311.
   PubMedGoogle Scholar
• Jorgensen WL, Madura JD. (1983). Quantum and statistical mechanical studies of liquids. 25. Solvation and conformation of methanol in water. J Am Chem Soc 105:1407–13.
   Web of Science ®Google Scholar
• Kamińska J, Głyda M, Sobiak J, Chrzanowska M. (2012). Pharmacokinetics of mycophenolic acid and its phenyl glucuronide metabolite in kidney transplant recipients with renal impairment. Arch Med Sci 1:88–96.
   Google Scholar
• Kaplan B, Gruber SA, Nallamathou R, et al. (1998). Decreased protein binding of mycophenolic acid associated with leukopenia in a pancreas transplant recipient with renal failure. Transplantation 65:1127–1129.
   PubMed Web of Science ®Google Scholar
• Kawase A, Yamamoto T, Egashira S, Iwaki M. (2016). Stereoselective inhibition of methotrexate excretion by glucuronides of nonsteroidal anti-inflammatory drugs via multidrug resistance proteins 2 and 4. J Pharmacol Exp Ther 356:366–74.
   PubMed Web of Science ®Google Scholar
• Kim CO, Cho SK, Oh ES, et al. (2012). Influence of ABCC2, SLCO1B1, and ABCG2 polymorphisms on the pharmacokinetics of olmesartan. J Cardiovasc Pharmacol 60:49–54.
   PubMed Web of Science ®Google Scholar
• Kirby WM, Regamey C. (1973). Pharmacokinetics of cefazolin compared with four other cephalosporins. J Infect Dis 128:S341–S6.
   PubMed Web of Science ®Google Scholar
• Kirschner KN, Yongye AB, Tschampel SM, et al. (2008). GLYCAM06: a generalizable biomolecular force field. carbohydrates. J Comput Chem 29:622–55.
   PubMed Web of Science ®Google Scholar
• Kuypers DRJ, Vanrenterghem Y, Squifflet JP, et al. (2003). Twelve-month evaluation of the clinical pharmacokinetics of total and free mycophenolic acid and its glucuronide metabolites in renal allograft recipients on low dose tacrolimus in combination with mycophenolate mofetil. Ther Drug Monit 25:609–622.
   PubMed Web of Science ®Google Scholar
• Lang T, Hitzl M, Burk O, et al. (2004). Genetic polymorphisms in the multidrug resistance-associated protein 3 (ABCC3, MRP3) gene and relationship to its mRNA and protein expression in human liver. Pharmacogenetics 14:155–64.
   PubMedGoogle Scholar
• Lempers VJC, van den Heuvel JJMW, Russel FGM, et al. (2016). Inhibitory potential of antifungal drugs on ATP-binding cassette transporters P-glycoprotein, MRP1 to MRP5, BCRP, and BSEP. Antimicrob Agents Chemother 60:3372–79.
   PubMed Web of Science ®Google Scholar
• Loncharich RJ, Brooks BR, Pastor RW. (1992). Langevin dynamics of peptides: the frictional dependence of isomerization rates of N-acetylalanyl-N'-methylamide. Biopolymers 32:523–35.
   PubMed Web of Science ®Google Scholar
• Maier JA, Martinez C, Kasavajhala K, et al. (2015). ff14SB: improving the accuracy of protein side chain and backbone parameters from ff99SB. J Chem Theory Comput 11:3696–713.
   PubMed Web of Science ®Google Scholar
• Marfo K, Altshuler J, Lu A. (2010). Tacrolimus pharmacokinetic and pharmacogenomic differences between adults and pediatric solid organ transplant recipients. Pharmaceutics 2:291–99.
   PubMedGoogle Scholar
• Matsunaga N, Wada S, Nakanishi T, et al. (2014). Mathematical modeling of the in vitro hepatic disposition of mycophenolic acid and its glucuronide in sandwich-cultured human hepatocytes. Mol Pharm 11:568–79.
   PubMed Web of Science ®Google Scholar
• Mattiello T, Guerriero R, Lotti LV, et al. (2011). Aspirin extrusion from human platelets through multidrug resistance protein-4-mediated transport: evidence of a reduced drug action in patients after coronary artery bypass grafting. J Am Coll Cardiol 58:752–61.
   PubMed Web of Science ®Google Scholar
• McGill MR, Jaeschke H. (2013). Metabolism and disposition of acetaminophen: recent advances in relation to hepatotoxicity and diagnosis. Pharm Res 30:2174–87.
   PubMed Web of Science ®Google Scholar
• Mizuno N, Takahashi T, Kusuhara H, et al. (2007). Evaluation of the role of breast cancer resistance protein (BCRP/ABCG2) and multidrug resistance-associated protein 4 (MRP4/ABCC4) in the urinary excretion of sulfate and glucuronide metabolites of edaravone (MCI-186; 3-methyl-1-phenyl-2-pyrazolin-5-one). Drug Metab Dispos 35:2045–2052.
   PubMed Web of Science ®Google Scholar
• Moes DJAR, Guchelaar H-J, de Fijter JW. (2015). Sirolimus and everolimus in kidney transplantation. Drug Discov Today 20:1243–49.
   PubMed Web of Science ®Google Scholar
• Morris GM, Huey R, Lindstrom W, et al. (2009). AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem 30:2785–91.
   PubMed Web of Science ®Google Scholar
• Mudge DW, Atcheson BA, Taylor PJ, et al. (2004). Severe toxicity associated with a markedly elevated mycophenolic acid free fraction in a renal transplant recipient. Ther Drug Monit 26:453–55.
   PubMed Web of Science ®Google Scholar
• Muilwijk EW, Lempers VJC, Burger DM, et al. (2015). Impact of special patient populations on the pharmacokinetics of echinocandins. Expert Rev Anti Infect Ther 13:799–815.
   PubMed Web of Science ®Google Scholar
• Nagelschmitz J, Blunck M, Kraetzschmar J, et al. (2014). Pharmacokinetics and pharmacodynamics of acetylsalicylic acid after intravenous and oral administration to healthy volunteers. Clin Pharmacol 6:51–59.
   PubMedGoogle Scholar
• Oh M, Shin J-G, Ahn S, et al. (2019). Pharmacokinetic comparison of a fixed-dose combination versus concomitant administration of amlodipine, olmesartan, and rosuvastatin in healthy adult subjects. Drug Des Dev Ther 13:991–97.
   PubMed Web of Science ®Google Scholar
• Oldham ML, Davidson AL, Chen J. (2008). Structural insights into ABC transporter mechanism. Curr Opin Struct Biol 18:726–33.
   PubMed Web of Science ®Google Scholar
• Parkinson A. (2019). Regulatory recommendations for calculating the unbound maximum hepatic inlet concentration: a complicated story with a surprising and happy ending. Drug Metab Dispos 47:779–84.
   PubMed Web of Science ®Google Scholar
• Patel CG, Ogasawara K, Akhlaghi F. (2013). Mycophenolic acid glucuronide is transported by multidrug resistance-associated protein 2 and this transport is not inhibited by cyclosporine, tacrolimus or sirolimus. Xenobiotica 43:229–35.
   PubMed Web of Science ®Google Scholar
• Picard N, Cresteil T, Prémaud A, Marquet P. (2004). Characterization of a phase 1 metabolite of mycophenolic acid produced by CYP3A4/5. Ther Drug Monit 26:600–608.
   PubMed Web of Science ®Google Scholar
• Picard N, Ratanasavanh D, Prémaud A, et al. (2005). Identification of the UDP-glucuronosyltransferase isoforms involved in mycophenolic acid phase II metabolism. Drug Metab. Dispos 33:139–46.
   PubMed Web of Science ®Google Scholar
• Picard N, Yee SW, Woillard J-B, et al. (2010). The role of organic anion-transporting polypeptides and their common genetic variants in mycophenolic acid pharmacokinetics. Clin Pharmacol Ther 87:100–108.
   PubMed Web of Science ®Google Scholar
• Rees DC, Johnson E, Lewinson O. (2009). ABC transporters: the power to change. Nat Rev Mol Cell Biol 10:218–27.
   PubMed Web of Science ®Google Scholar
• Reid G, Wielinga P, Zelcer N, et al. (2003). The human multidrug resistance protein MRP4 functions as a prostaglandin efflux transporter and is inhibited by nonsteroidal antiinflammatory drugs. Proc Natl Acad Sci USA 100:9244–49.
   PubMed Web of Science ®Google Scholar
• Rius M, Hummel-Eisenbeiss J, Keppler D. (2008). ATP-dependent transport of leukotrienes B4 and C4 by the multidrug resistance protein ABCC4 (MRP4). J Pharmacol Exp Ther 324:86–94.
   PubMed Web of Science ®Google Scholar
• Rius M, Nies AT, Hummel-Eisenbeiss J, et al. (2004). The export pump MRP4 (ABCC4) is localized to the basolateral membrane of hepatocytes and mediates cotransport of reduced glutathione with bile salts. Z Gastroenterol 42:AB_2_70.
   Google Scholar
• Schaub T P, Kartenbeck J, König J, et al. (1999). Expression of the MRP2 gene-encoded conjugate export pump in human kidney proximal tubules and in renal cell carcinoma. J Am Soc Nephrol 10:1159–1169.
   Google Scholar
• Scheffer GL, Kool M, de Haas M, et al. (2002). Tissue distribution and induction of human multidrug resistant protein 3. Lab Investig 82:193–201.
   PubMed Web of Science ®Google Scholar
• Shipkova M, Armstrong VW, Wieland E, et al. (1999). Identification of glucoside and carboxyl-linked glucuronide conjugates of mycophenolic acid in plasma of transplant recipients treated with mycophenolate mofetil. Br J Pharmacol 126:1075–1082.
   PubMed Web of Science ®Google Scholar
• Sobiak J, Kamińska J, Głyda M, et al. (2013). Effect of mycophenolate mofetil on hematological side effects incidence in renal transplant recipients. Clin Transplant 27:E407–14.
   PubMed Web of Science ®Google Scholar
• Staatz CE, Tett SE. (2007). Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients. Clin Pharmacokinet 46:13–58.
   PubMed Web of Science ®Google Scholar
• Trauner M, Boyer JL. (2003). Bile salt transporters: molecular characterization, function, and regulation. Physiol Rev 83:633–71.
   PubMed Web of Science ®Google Scholar
• Trott O, Olson AJ. (2010). AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 31:455–61.
   PubMed Web of Science ®Google Scholar
• Uwai Y, Motohashi H, Tsuji Y, et al. (2007). Interaction and transport characteristics of mycophenolic acid and its glucuronide via human organic anion transporters hOAT1 and hOAT3. Biochem Pharmacol 74:161–68.
   PubMed Web of Science ®Google Scholar
• Vassetti D, Pagliai M, Procacci P. (2019). Assessment of GAFF2 and OPLS-AA general force fields in combination with the water models TIP3P, SPCE, and OPC3 for the solvation free energy of druglike organic molecules. J Chem Theory Comput 15:1983–95.
   PubMed Web of Science ®Google Scholar
• Wang J, Wang W, Kollman PA, Case DA. (2006). Automatic atom type and bond type perception in molecular mechanical calculations. J Mol Graphics Model 25:247–60.
   PubMed Web of Science ®Google Scholar
• Wang J, Wolf RM, Caldwell JW, et al. (2004). Development and testing of a general amber force field. J Comput Chem 25:1157–74.
   PubMed Web of Science ®Google Scholar
• Wang L, Prasad B, Salphati L, et al. (2015). Interspecies variability in expression of hepatobiliary transporters across human, dog, monkey, and rat as determined by quantitative proteomics. Drug Metab Dispos 43:367–74.
   PubMed Web of Science ®Google Scholar
• Wittgen HGM, van den Heuvel JJMW, Krieger E, et al. (2012). Phenylalanine 368 of multidrug resistance-associated protein 4 (MRP4/ABCC4) plays a crucial role in substrate-specific transport activity. Biochem Pharmacol 84:366–73.
   PubMed Web of Science ®Google Scholar
• Wolff NA, Burckhardt BC, Burckhardt G, et al. (2007). Mycophenolic acid (MPA) and its glucuronide metabolites interact with transport systems responsible for excretion of organic anions in the basolateral membrane of the human kidney. Nephrol Dial Transplant 22:2497–503.
   PubMed Web of Science ®Google Scholar
• Yamada A, Maeda K, Kamiyama E, et al. (2007). Multiple human isoforms of drug transporters contribute to the hepatic and renal transport of olmesartan, a selective antagonist of the angiotensin II AT1-receptor. Drug Metab Dispos 35:2166–76.
   PubMed Web of Science ®Google Scholar
• Zamek-Gliszczynski MJ, Hoffmaster KA, Nezasa K-I, et al. (2006). Integration of hepatic drug transporters and phase II metabolizing enzymes: mechanisms of hepatic excretion of sulfate, glucuronide, and glutathione metabolites. Eur J Pharm Sci 27:447–86.
   PubMed Web of Science ®Google Scholar
• Zamek-Gliszczynski MJ, Nezasa K-I, Tian X, et al. (2006). Evaluation of the role of multidrug resistance-associated protein (Mrp) 3 and Mrp4 in hepatic basolateral excretion of sulfate and glucuronide metabolites of acetaminophen, 4-methylumbelliferone, and harmol in Abcc3-/- and Abcc4-/- mice. J Pharmacol Exp Ther 319:1485–91.
   PubMed Web of Science ®Google Scholar